RCUS
Arcus Biosciences Inc.
$23.12
+$0.41(+1.81%)
59
Overall
60
Value
58
Tech
--
Quality
Market Cap
$2.45B
Volume
444.83K
52W Range
$6.50 - $26.40
Target Price
$33.70
Company Overview
| Mkt Cap | $2.45B | Price | $23.12 |
| Volume | 444.83K | Change | +1.81% |
| P/E Ratio | -8.7 | Open | $22.83 |
| Revenue | $258.0M | Prev Close | $22.71 |
| Net Income | $-283.0M | 52W Range | $6.50 - $26.40 |
| Div Yield | N/A | Target | $33.70 |
| Overall | 59 | Value | 60 |
| Quality | -- | Technical | 58 |
No chart data available
Latest News
These Are the Most and Least Likely Biotech Takeover Targets for 2026
Vince Condarcuri•3 days ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: BioCryst (BCRX), Arcus Biosciences (RCUS) and Amicus (FOLD)
Brian Anderson•12 days ago
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
William White•14 days ago
Arcus Biosciences Stock (RCUS) Collapses 17% after Failed Stomach Cancer Study
David Craik•14 days ago
Arcus Biosciences Ends Phase 3 STAR-221 Study
TipRanks Auto-Generated Newsdesk•14 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RCUS | $23.12 | +1.8% | 444.83K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |